As of 2025-03-19, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (116.82) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -253.7%.
The range of the Relative Valuation is (118.68) - (163.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 27.2x | 17.5x |
| Forward P/E multiples | 16.1x - 23.8x | 16.4x |
| Fair Price | (118.68) - (163.76) | (116.82) |
| Upside | -256.1% - -315.4% | -253.7% |
| Date | P/E |